What changes in your body after menopause and what that means for your joints and muscles
Nicola Tik
After menopause, the hormonal landscape of the body settles into a new and permanent state. The fluctuations of perimenopause give way to a consistently lower level of oestrogen, the hormone that plays a central role in maintaining joint health, muscle mass, bone density, and pain sensitivity. Understanding what that change means for the body in the longer term makes it easier to look after your MSK health effectively during this stage of life.
The physical experience of postmenopause is distinct from perimenopause in an important way. During perimenopause, oestrogen levels fluctuate unpredictably, which produces variable and sometimes inconsistent symptoms. After menopause, oestrogen levels are consistently low rather than fluctuating. The variability settles, but the body is now operating within a permanently changed hormonal environment.
This distinction matters for how the MSK changes of postmenopause are understood and managed. The joint stiffness, muscle changes, and pain sensitivity of this stage are not driven by hormonal instability. They reflect the body adapting to a new baseline, and the strategies that support the MSK system most effectively are ones built around that longer-term reality rather than around managing day-to-day variability.
Oestrogen, the hormone responsible for regulating many of the body's systems beyond reproduction, plays a direct role in maintaining the health of joint tissue, including the cartilage that cushions joints and the fluid that keeps them lubricated. With oestrogen consistently low after menopause, the joint environment changes in ways that are more stable than during perimenopause but also more established.
Many people find that joint stiffness and aching, particularly in the hands, knees, hips, and lower back, become a more consistent feature of daily life after menopause than they were before. The joints may feel less well lubricated first thing in the morning, more reactive to sustained or unaccustomed load, and slower to settle after periods of increased activity. These changes are a direct consequence of the altered hormonal environment rather than a sign of damage or accelerated ageing, and they respond well to consistent, appropriate management.
One of the most significant MSK changes of postmenopause is the effect of consistently low oestrogen on bone density. Oestrogen plays an active role in the process by which the body maintains and renews bone tissue. When oestrogen levels decline and remain low, bone renewal becomes less efficient, and bone density can reduce more quickly than it would during earlier stages of life.
This does not mean that bone loss after menopause is inevitable or unmanageable. The skeleton responds to load, and bones that are regularly asked to bear weight and manage impact maintain their density more effectively than bones that are not. Weight-bearing activity, from walking and climbing stairs to strength training and dancing, provides the mechanical stimulus that bones need to maintain and rebuild density. This is one of the most well-evidenced and accessible tools available for supporting bone health after menopause, and its benefits extend well beyond the skeleton to the muscles and joints that support it.
Oestrogen supports the maintenance of muscle mass and the efficiency of muscle recovery after effort. With oestrogen consistently low after menopause, the rate at which muscle mass is maintained without deliberate effort slows. Muscles may feel less responsive than they used to, recover more slowly after physical effort, and reduce in mass more readily during periods of inactivity than they would have at an earlier hormonal stage.
The practical consequence of reduced muscle mass is significant for MSK health, because muscle is one of the primary protectors of joints. Strong muscles absorb load, stabilise joints, and reduce the demand placed directly on cartilage and bone during everyday activity. Maintaining muscle mass after menopause is therefore not simply about physical fitness. It is directly relevant to joint protection and long-term MSK resilience.
Oestrogen has a moderating effect on the nervous system's processing of pain signals. With consistently low oestrogen after menopause, that moderating effect is reduced, and the body may register pain and discomfort more readily than it did during earlier hormonal stages. This can mean that existing joint and muscle aches feel more prominent, and that the threshold at which physical effort tips from comfortable into uncomfortable is lower than it used to be.
Understanding this as a physiological reality rather than a sign of something going wrong makes it easier to respond to it usefully. It does not mean reducing activity or avoiding load. It means being attentive to how the body is responding and adjusting effort accordingly, which is a more sustainable approach than either pushing through significant discomfort or becoming cautious about movement altogether.